TJM Labs, the leading pharmacy AI platform automating operational work for pharmacies, announces it has raised $100 million across three funding rounds in approximately six months: a $10 million Series A, a $15 million Series A-1, and a $75 million Series B led by Elephant, with participation from Arthur Ventures and Updata. The company also announced it is now live in 450+ pharmacies and has completed two acquisitions, EncoreRx and Pharmesol, expanding its automation and voice capabilities into a single pharmacy-native platform.
Read the full article: TJM Labs Announces $100M Raised, 450+ Live Pharmacies, and Two Acquisitions as It Defines Pharmacy AI //
Source: https://www.einpresswire.com/article/923670384/tjm-labs-announces-100m-raised-450-live-pharmacies-and-two-acquisitions-as-it-defines-pharmacy-ai